(Press-News.org) Tampa, FL, USA – The Global Virus Network (GVN), a coalition of leading human and animal virologists from 80+ Centers of Excellence and Affiliates in more than 40 countries dedicated to advancing pandemic preparedness, is unequivocally committed to the continued development and deployment of mRNA vaccines and the global scientific collaboration that makes such innovation possible.
Vaccination remains one of public health’s greatest achievements, preventing an estimated 4.4 million deaths globally each year. Building on this foundation, mRNA vaccine platforms have emerged as one of the most significant biomedical innovations of the 21st century, fundamentally reshaping our ability to respond rapidly and effectively to emerging viral threats. The real-world impact of mRNA vaccines has been striking. Between 2020 and 2024, COVID-19 vaccines are estimated to have prevented approximately 7.5 million deaths globally. In the United States alone, over 298 million mRNA vaccine doses were administered within the first six months of rollout, with fewer than 1% of recipients experiencing significant adverse reactions or complications. Furthermore, clinical data showed that between March 2021 and January 2022, mRNA vaccines reduced the death rate by about 90%, and were 94% effective against severe disease during the Omicron wave.
Unlike traditional vaccines, which use weakened or inactivated viruses or parts of the pathogen to stimulate immunity, mRNA vaccines deliver synthetic genetic instructions that teach cells to produce a harmless viral protein. This approach primes the immune system without exposing individuals to the actual pathogen, offering a safe and adaptable platform with broad potential. Although propelled into the global spotlight by COVID-19, mRNA technology has been under development for decades, with early applications targeting rabies, influenza, and Zika, and more recently, showing promise in cancer immunotherapy.
"mRNA vaccine technology has fundamentally changed our ability to respond quickly and precisely to emerging viral threats," said Johan Neyts, PhD, Director of the GVN Center of Excellence at KU Leuven in Belgium, and a global leader in antiviral drug and vaccine development. "Various members of the GVN are working across continents to accelerate innovation in mRNA-based vaccines, not only for coronaviruses but also for dengue, Zika, Lassa fever, and other high-consequence pathogens."
The GVN emphasizes that scientific transparency, public health engagement, and a global commitment to research must remain at the heart of mRNA vaccine deployment strategies. "Global acceptance of vaccines, especially new platforms like mRNA, depends not only on scientific rigor but also on building and sustaining trust within communities," said Heidi Larson, PhD, Founding Director of the Vaccine Confidence Project and an internationally recognized expert in vaccine confidence and risk communication. " The GVN serves a critical function in this effort by convening trusted scientific voices around the world and advancing transparent, culturally informed engagement that helps bridge the gap between innovation and public confidence."
Around the world, governments and research institutions are advancing mRNA development and infrastructure as part of their pandemic preparedness and public health strategies. From South Africa to South Korea, Brazil to Belgium, GVN Centers are playing pivotal roles in these efforts.
“South Africa is leading a transformative moment in global health by building sustainable mRNA vaccine research and manufacturing ecosystems,” said Quarraisha Abdool Karim, PhD, Co-Director of the GVN Center of Excellence at CAPRISA in South Africa and an internationally esteemed epidemiologist advancing health equity and scientific capacity across Africa. “By harnessing mRNA innovation locally, we’re not only responding to today’s needs but also empowering future generations of African scientists.”
The GVN stands committed to advocating for a globally coordinated approach to the development and deployment of mRNA vaccines that includes:
Expanding mRNA research and manufacturing capacity in low- and middle-income countries to close gaps in access and build regional resilience.
Supporting next-generation mRNA innovation, including thermostable and self-amplifying formulations, to improve global distribution and longevity.
Combating vaccine misinformation through collaborative initiatives with educators, journalists, and community leaders to ensure scientifically accurate, culturally sensitive messaging.
As a science-driven organization, the GVN is dedicated to advancing pandemic preparedness by fostering the exchange of knowledge, building global training capacity, accelerating translational research, and supporting effective and equitable responses to viral threats. mRNA vaccines are not just a product of biomedical ingenuity; they are a testament to what global collaboration can achieve when rooted in evidence and transparency.
###
About the Global Virus Network (GVN)
The Global Virus Network (GVN) is a worldwide coalition comprising 80+ Virology Centers of Excellence and Affiliates across 40+ countries, whose mission is to facilitate pandemic preparedness against viral pathogens and diseases that threaten public health globally. GVN advances knowledge of viruses through (i) data-driven research and solutions, (ii) fostering the next generation of virology leaders, and (iii) enhancing global resources for readiness and response to emerging viral threats. GVN provides the essential expertise required to discover and diagnose viruses that threaten public health, understand how such viruses spread illnesses, and facilitate the development of diagnostics, therapies, and treatments to combat them. GVN coordinates and collaborates with local, national, and international scientific institutions and government agencies to provide real-time virus informatics, surveillance, and response resources and strategies. GVN's pandemic preparedness mission is achieved by focusing on Education & Training, Qualitative & Quantitative Research, and Global Health Strategies & Solutions. The GVN is a non-profit 501(c)(3) organization. For more information, please visit www.gvn.org.
Media Contact:
Nora Samaranayake
nsamaranayake@gvn.org
END
Images
To help manage agricultural practices with fewer or no pesticides, University of Michigan researchers say they need to understand how ecological systems work on agricultural lands.
Now, U-M researchers John Vandermeer and Ivette Perfecto have used two ecological theories to describe a tangle of interactions between three ant species and a recently introduced fly that preys on one of the ant species. Their work on a coffee farm in Puerto Rico shows that the interaction between the ants and the predator fly creates chaotic patterns—chaos in ...
Water is essential for life on Earth. So, the liquid must be a requirement for life on other worlds. For decades, scientists’ definition of habitability on other planets has rested on this assumption.
But what makes some planets habitable might have very little to do with water. In fact, an entirely different type of liquid could conceivably support life in worlds where water can barely exist. That’s a possibility that MIT scientists raise in a study appearing this week in the Proceedings of the National Academy of Sciences.
From lab experiments, the researchers found that a type of fluid known as an ionic liquid can readily ...
ITHACA, N.Y. – When cells expire, they leave behind an activity log of sorts: RNA expelled into blood plasma that reveal changes in gene expression, cellular signaling, tissue injury and other biological processes.
Cornell University researchers developed machine-learning models that can sift through this cell-free RNA and identify key biomarkers for myalgic encephalomyelitis, also known as chronic fatigue syndrome (ME/CFS). The approach could lead to the development of diagnostic testing for a debilitating disease that has proved challenging ...
CAMBRIDGE, MA – The cost of solar panels has dropped by more than 99 percent since the 1970s, enabling widespread adoption of photovoltaic systems that convert sunlight into electricity.
A new MIT study drills down on specific innovations that enabled such dramatic cost reductions, revealing that technical advances across a web of diverse research efforts and industries played a pivotal role.
The findings could help renewable energy companies make more effective R&D investment decisions and aid policymakers in identifying areas to prioritize to spur growth in manufacturing and deployment.
The ...
Groundbreaking research led by a Swansea University academic has revealed a synthetic glycosystem — a sugar-coated polymer nanoparticle — that can block Covid-19 from infecting human cells, reducing infection rates by nearly 99%.
The glycosystem is a specially designed particle that mimics natural sugars found on human cells. These sugars, known as polysialosides, are made of repeating units of sialic acid — structures that viruses often target to begin infection. By copying this structure, the synthetic molecule acts as a decoy, binding to the virus’s spike protein and preventing it from attaching to real cells.
Unlike vaccines, which trigger immune responses, ...
Rice University computer scientist Luay Nakhleh, who also serves as the dean of the George R. Brown School of Engineering and Computing, has received a $1.9 million grant from the National Science Foundation to build a powerful new software infrastructure that could significantly expand how scientists study evolution. The project, titled PhyNetPy, aims to bring the next generation of evolutionary modeling tools into the hands of researchers around the world by enabling the widespread use of phylogenetic networks — complex, ...
A research team at McMaster University has discovered a new drug class that could someday lead to breakthrough treatments for dangerous fungal infections.
The new molecules, dubbed coniotins, were isolated from a plant-dwelling fungus called Coniochaeta hoffmannii — the samples of which were collected from the McMaster greenhouse, located on the university’s campus.
Detailed recently in the journal Nature Communications, the discovery responds to a critical need for new antifungal medicines.
“There is a huge, growing clinical need for new drugs that target fungal infections,” says Gerry Wright, a ...
Scientists have created new way to characterise graphene oxide (GO) cheaper and quicker than ever before, helping get the emerging technology out of the lab and into the market.
Researchers at King’s College London have designed an ‘interactional fingerprinting’ method that creates a unique identity of individual samples. By mimicking humans’ sense of taste and smell, the method can create a qualitative snapshot of the material without relying on inaccessible gold-standard measurement machinery manned by teams of specialists.
By promising a faster and cheaper way to quality control graphene oxide, the scientists ...
From lifelong farmers to backyard gardeners, most plant-lovers know that adding organic matter to a field, vegetable plot or flowerpot increases the soil’s moisture.
Now, for the first time, Northwestern University scientists have uncovered the molecular mechanisms that enable organic matter to boost soil’s ability to retain water — even in desert-like conditions.
Carbohydrates — key components of plants and microbes — act like a molecular glue, using water to form sticky bridges between organic molecules and soil minerals, the team found. These bridges lock in moisture that ...
A researcher at The University of Texas at Arlington is helping a leading national cancer center explore how wearable devices could help childhood cancer survivors avoid long-term health complications such as diabetes and heart disease. Yue Liao, assistant professor of kinesiology at UT Arlington, was invited by researchers at City of Hope, a National Cancer Institute-designated comprehensive cancer center, to contribute to a review article published in Cancer. The article examines how survivors of childhood cancer face elevated risks of chronic conditions such as diabetes and how digital health tools could help detect—and possibly prevent—these ...
